Strengthening Tourette Treatment Options Using TMS to Improve CBIT

This study is looking at how repetitive transcranial magnetic stimulation (rTMS) might help adults with Tourette Syndrome when combined with comprehensive behavioral intervention for tics (CBIT). Participants will be adults aged 18 to 100 with moderate tic severity. You would receive either active rTMS or a sham (inactive) rTMS, followed by eight CBIT sessions. Researchers want to see if rTMS can make CBIT more effective at reducing tic frequency and severity. The study aims to enroll 20 participants, but its current status is unclear.

Study design
This is a double-blind, randomized, controlled pilot study. It plans to enroll 20 participants.
What's involved
Participants will receive eight CBIT sessions after either active or sham rTMS. The study will measure tic severity for about 3 months.
Compensation
Not stated in the trial record.
Follow-up
Your tic severity will be measured through study completion, which averages 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05705999

Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study

Recruiting
NAAges 18+InterventionalTreatment
West Virginia University
~20 participants
Updated 2025-07-18 on ClinicalTrials.gov
What's tested:transcranial magnetic stimulation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Yale Global Tic Severity Scale (YGTSS)
Measured over Through study completion, an average of 3 months
+1 more outcome measured
Tourette Syndrome
1 sites across 1 states
West Virginia1
  • Jessica Frey, MD · PRINCIPAL_INVESTIGATOR · WVU RNI

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
Diagnosis of Tourette Syndrome
Moderate Tic Severity at baseline

Exclusion

Presence of metallic objects or neurostimulators in the brain
Pregnancy
History of active seizures or epilepsy
Contraindications to receiving fMRI
Inability to participate in CBIT due to other underlying cognitive or medical condition
  • Yale Global Tic Severity Scale (YGTSS)Through study completion, an average of 3 months

    Tic severity will be measured with YGTSS. YGTSS is a clinician-rated scale used to assess tic severity, scored out of 100 where a higher score indicates greater tic frequency and severity. It includes a checklist of motor and vocal tics followed by an assessment of the number, frequency, intensity, complexity, and inference of motor tics and phonic tics - scored separately. Each of these dimensions is scored on a 0 to 5 scale. The YGTSS provides three tic severity scores: Total Motor (0 to 25); Total Phonic (0 to 25) and the combined Total Tic Severity Score (0 to 50), as well as a separate Impairment dimension scored from 0 to 50.

  • Modified Rush Videotape Tic Rating Scale (mRVTRS)Through study completion, an average of 3 months

    This is a tool used by an objective examiner to quantify the severity of a patient's tics by rating the number of body areas affected, motor tic frequency, phonic tic frequency, motor tic severity, and phonic tic severity, each on a 0 through 4 score by watching a video of the patient. Scored out of 20, where a higher score indicates greater tic severity.